NCT04430049View on ClinicalTrials.gov

Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients

CompletedOBSERVATIONAL
Enrollment

811

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

November 9, 2022

Study Completion Date

November 9, 2022

Conditions
Covid-19Family MembersCritical Illness
Interventions
PROCEDURE

Covid ICU containment measures

The french containment measures during Covid-19 pandemic result in a restrictive visitation for relatives in ICU

Trial Locations (11)

12000

CH Rodez, Rodez

15000

CH Aurillac, Aurillac

24000

CH Périgueux, Périgueux

38000

CH Grenoble, Grenoble

43000

CH Le Puy-en-Velay, Le Puy-en-Velay

63000

University hospital, Clermont-Ferrand, Clermont-Ferrand

Centre Jean Perrin, Clermont-Ferrand

69000

University hopistal, Lyon, Lyon

06150

CH Cannes, Cannes

03000

CH Moulins, Moulins

03200

CH Vichy, Vichy

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT04430049 - Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients | Biotech Hunter | Biotech Hunter